MX2018000418A - Derivados de amida que tienen actividad multimodal contra el dolor. - Google Patents
Derivados de amida que tienen actividad multimodal contra el dolor.Info
- Publication number
- MX2018000418A MX2018000418A MX2018000418A MX2018000418A MX2018000418A MX 2018000418 A MX2018000418 A MX 2018000418A MX 2018000418 A MX2018000418 A MX 2018000418A MX 2018000418 A MX2018000418 A MX 2018000418A MX 2018000418 A MX2018000418 A MX 2018000418A
- Authority
- MX
- Mexico
- Prior art keywords
- amide derivatives
- activity against
- against pain
- multimodal activity
- pain
- Prior art date
Links
- 150000001408 amides Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000051367 mu Opioid Receptors Human genes 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 108020001612 μ-opioid receptors Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se refiere a compuestos que tienen actividad farmacológica dual hacia el receptor sigma (s) y el receptor opioide µ, a procesos de preparación de dichos compuestos, a composiciones farmacéuticas que los comprenden y a su uso en terapia, en particular para el tratamiento del dolor.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15382391 | 2015-07-29 | ||
| PCT/EP2016/001309 WO2017016668A1 (en) | 2015-07-29 | 2016-07-28 | Amide derivatives having multimodal activity against pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018000418A true MX2018000418A (es) | 2018-08-14 |
Family
ID=54056149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018000418A MX2018000418A (es) | 2015-07-29 | 2016-07-28 | Derivados de amida que tienen actividad multimodal contra el dolor. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10351549B2 (es) |
| EP (1) | EP3328847B1 (es) |
| JP (1) | JP2018521090A (es) |
| CN (1) | CN107922384A (es) |
| CA (1) | CA2992054A1 (es) |
| ES (1) | ES2760625T3 (es) |
| HK (1) | HK1255248A1 (es) |
| MX (1) | MX2018000418A (es) |
| WO (1) | WO2017016668A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024105225A1 (en) | 2022-11-18 | 2024-05-23 | Universitat De Barcelona | Synergistic combinations of a sigma receptor 1 (s1r) antagonist and a soluble epoxide hydrolase inhibitor (sehi) and their use in the treatment of pain |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1585165A (en) | 1976-06-29 | 1981-02-25 | Leo Pharm Prod Ltd | Derivatives of 6-amidino penicillanic acid |
| US4894453A (en) | 1986-06-30 | 1990-01-16 | Toyo Jozo Kabushiki Kaisha | 2-substituted alkoxy-3-substituted-pyrazines |
| JPH11130761A (ja) * | 1997-10-24 | 1999-05-18 | Otsuka Pharmaceut Co Ltd | ベンゾチアゾール誘導体 |
| US20030022891A1 (en) * | 2000-12-01 | 2003-01-30 | Anandan Palani | MCH antagonists and their use in the treatment of obesity |
| FI110636B (fi) * | 2001-06-29 | 2003-02-28 | Teknoware Oy | Järjestely valaisimen yhteydessä ja valaisin |
| SI1499607T1 (sl) | 2001-12-04 | 2006-06-30 | Actelion Pharmaceuticals Ltd | 4-(piperidil- in pirolidil-alkil-ureido)-kinolinikot antagonisti receptorja urotensina II |
| US7521457B2 (en) | 2004-08-20 | 2009-04-21 | Boehringer Ingelheim International Gmbh | Pyrimidines as PLK inhibitors |
| RU2709482C1 (ru) * | 2013-12-20 | 2019-12-18 | Эстеве Фармасьютикалз, С.А. | Производные пиперазина, характеризующиеся мультимодальной активностью в отношении боли |
| US9981942B2 (en) | 2013-12-20 | 2018-05-29 | Laboratorios Del Dr. Esteve S.A. | Piperidine derivatives having multimodal activity against pain |
-
2016
- 2016-07-28 JP JP2018503652A patent/JP2018521090A/ja active Pending
- 2016-07-28 US US15/747,220 patent/US10351549B2/en not_active Expired - Fee Related
- 2016-07-28 WO PCT/EP2016/001309 patent/WO2017016668A1/en not_active Ceased
- 2016-07-28 ES ES16744665T patent/ES2760625T3/es active Active
- 2016-07-28 HK HK18114384.5A patent/HK1255248A1/zh unknown
- 2016-07-28 EP EP16744665.7A patent/EP3328847B1/en active Active
- 2016-07-28 CN CN201680043614.5A patent/CN107922384A/zh active Pending
- 2016-07-28 CA CA2992054A patent/CA2992054A1/en not_active Abandoned
- 2016-07-28 MX MX2018000418A patent/MX2018000418A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2992054A1 (en) | 2017-02-02 |
| WO2017016668A1 (en) | 2017-02-02 |
| ES2760625T3 (es) | 2020-05-14 |
| JP2018521090A (ja) | 2018-08-02 |
| US20180237415A1 (en) | 2018-08-23 |
| CN107922384A (zh) | 2018-04-17 |
| US10351549B2 (en) | 2019-07-16 |
| EP3328847A1 (en) | 2018-06-06 |
| HK1255248A1 (zh) | 2019-08-09 |
| EP3328847B1 (en) | 2019-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018000419A (es) | Derivados de amida sustituida que tienen actividad multimodal contra el dolor. | |
| MX2023010042A (es) | Polinucleotidos moduladores. | |
| PH12018500586A1 (en) | Farnesoid x receptor agonists and uses thereof | |
| PH12016500978A1 (en) | Piperazine derivatives having multimodal activity against pain | |
| TW201613901A (en) | New compounds | |
| MX2017006437A (es) | Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor. | |
| MX2020009780A (es) | Compuestos de inhibidor de autotaxina. | |
| MX2016006604A (es) | Derivados de piperidina con actividad multimodal contra el dolor. | |
| MY199091A (en) | Therapeutic compounds | |
| PH12016502307A1 (en) | Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain | |
| PH12016501527A1 (en) | Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient | |
| MX395492B (es) | Usos terapeuticos de l-4 cloroquinurenina. | |
| MX2016006603A (es) | Compuestos piperidinicos con actividad multimodal contra el dolor. | |
| MX2017006513A (es) | Compuestos de tipo 1,9-diazaespiroundecano con actividad multimodal contra el dolor. | |
| MX2020009966A (es) | Formas de dosificacion y usos terapeuticos de la l-4-cloro quinurenina. | |
| PH12018500814A1 (en) | Oxadiazaspiro compounds for the treatment of drug abuse and addiction | |
| PH12018502280A1 (en) | Tetrahydropyran and thiopyran derivatives having multimodal activity against pain | |
| IN2013MU03118A (es) | ||
| PH12017501979A1 (en) | Pharmaceutical compound | |
| PH12018500682A1 (en) | Oxa-diazaspiro compounds having activity against pain | |
| MX2018004774A (es) | Derivados de morfolina sustituidos que tienen actividad contra el dolor. | |
| MX2018000418A (es) | Derivados de amida que tienen actividad multimodal contra el dolor. | |
| MX2018004776A (es) | Compuestos oxaazaespiricos con actividad contral el dolor. | |
| HK1244003A1 (en) | Spiro-isoquinoline-1,4'-piperidine compounds having multimodal activity against pain | |
| HK1241862A1 (en) | 1,9-diazaspiro undecane compounds having multimodal activity against pain |